Skip to main content
. 2020 Jan 3;2020:4739271. doi: 10.1155/2020/4739271

Table 1.

Comparison of clinical characteristics among different groups.

Clinical measurement Normal control (NC group, n = 40) Diabetes without macroangiopathy (NM group, n = 90) Diabetes with macroangiopathy (MA group, n = 83) P value
Age (y) 50.98 ± 13.83 53.81 ± 11.87 54.49 ± 8.37 0.247
Male, n (%) 18 (45.0) 44 (48.9) 38 (45.8) 0.886
Cigarette smoking (%) 13 (32.5) 34 (37.8) 33 (39.8) 0.737
Alcohol drinking (%) 25 (62.5) 60 (66.7) 55 (66.3) 0.891
BMI (kg/m2) 22.04 ± 2.95 24.31 ± 2.85 24.61 ± 3.23 <0.001
Diabetes duration (y) 5 (1, 8.5) 8 (4.33, 14)# <0.001
SBP (mmHg) 117.25 ± 7.90 130.60 ± 4.39 159.70 ± 14.23∗# <0.001
DBP (mmHg) 74.70 ± 6.53 81.99 ± 4.09 90.24 ± 9.48∗# <0.001
FPG (mmol/L) 5.33 ± 0.56 9.13 ± 2.45 10.20 ± 2.74∗# <0.001
PPG (mmol/L) 6.34 ± 0.67 14.49 ± 3.63 15.85 ± 4.08∗# <0.001
HbA1C (%) 5.50 ± 0.63 8.67 ± 1.61 8.83 ± 1.73 <0.001
TC (mmol/L) 4.36 ± 0.73 4.94 ± 1.13 5.13 ± 0.94 <0.001
TG (mmol/L) 1.31 ± 0.78 1.57 ± 0.76 1.74 ± 0.99 0.036
HDL-C (mmol/L) 1.32 ± 0.39 1.14 ± 0.26 1.09 ± 0.29 <0.001
LDL-C (mmol/L) 2.93 ± 0.87 3.14 ± 0.88 3.44 ± 0.92∗# 0.008
UA (mmol/L) 309.68 ± 92.27 343.85 ± 73.26 386.96 ± 90.07∗# <0.001
Fg (g/L) 3.06 ± 0.94 3.53 ± 0.87 4.02 ± 1.02∗# <0.001
Fins (μU/mL) 35.73 ± 7.83 72.90 ± 14.89 155.16 ± 41.30∗# <0.001
HOMA2-IR 0.67 ± 0.14 1.53 ± 0.31 3.33 ± 0.78∗# <0.001
hs-CRP (mg/L) 0.92 (0.74, 2.14) 2.14 (1.00, 3.83) 4.02 (2.14, 5.75)∗# <0.001
D-IMT (cm) 0.0276 ± 0.0099 0.0538 ± 0.0075 0.1135 ± 0.0222∗# <0.001

Significantly different from the NC group. #Significantly different from the NM group. BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; FPG: fasting plasma glucose; PPG: postprandial 2 hours blood glucose; HbA1C: glycosylated hemoglobin; TC: total cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; UA: uric acid; Fg: fibrinogen; Fins: fasting insulin; HOMA2-IR: homeostasis model assessment 2 of insulin resistance; hs-CRP: high-sensitivity C-reactive protein; D-IMT: intima media thickness of the dorsalis pedis artery. Measurement data are presented as mean ± standard deviation or median (with interquartile ranges).